Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE

Pfizer Inc. and PlaNet Finance to Study Options for Expanding Access to Healthcare in China

By Pharmaceutical Processing | March 20, 2009

NEW YORK & PARIS– (BUSINESS WIRE) — Mar. 20, 2009– Pfizer Inc and PlaNet Finance announced today that they will team up to conduct an in-depth research project on the healthcare needs of the working poor in China. The study will examine the availability and existing sources of medicines, patient purchasing patterns, and the level of access to medical services. The study ultimately aims to help both organizations identify models that may enhance and expand access to medicines and healthcare services for the working poor in China. The Chinese Ministry of Health recently released the results of its 4th National Health Survey, an extensive document covering healthcare patterns across the country. The Pfizer and PlaNet Finance collaboration is designed to solicit additional information from low-income populations in China to complement existing and planned government efforts to improve healthcare. Pfizer’s mission in China is to meet the diverse medical needs of the country’s population through a broad portfolio of innovative medicines and partnerships with local healthcare providers, academics, and government in order to support the rapid development of the country’s healthcare system. “Pfizer’s partnership with PlaNet Finance is aligned with the strategy to expand our geographic reach across China. I am extremely confident that this partnership will also achieve the broader aim of identifying unique and workable solutions for the diverse medical needs of patients in Emerging Markets,” stated Jean-Michel Halfon, President & General Manager of Pfizer’s Emerging Markets Business Unit. “This is another step forward under our Global Access program, which is unique in that we are taking a broad, holistic approach to understanding the various barriers to healthcare access, so that we can implement solutions that are effective and sustainable.” For over ten years, and in over 60 countries, PlaNet Finance has been active in development and financing in the microfinance and microinsurance sectors. “Healthcare plays a major role in the fight against poverty. PlaNet Finance understands this challenge and has developed specific programs which link microfinance to healthcare -leveraging existing microfinance institution (MFI) infrastructure to implement awareness and prevention campaigns for malaria, HIV/AIDS, and other diseases. PlaNet Finance has also developed sustainable life and health insurance solutions for low-income populations through its subsidiary PlaNet Guarantee dedicated to microinsurance,” explained PlaNet Finance President Jacques Attali. “We are very pleased to team up with Pfizer; this partnership will enhance our work in meaningful and lasting ways to reach out to such a vital part of Chinese society to determine their healthcare needs.” This collaboration with an international non-profit organization, expert in microfinance and microinsurance, marks another milestone for Pfizer in its goal to increase access to medicines for more patients in the developing world. The company reiterated its position to adopt strategies that are commercially viable and socially responsible. Pfizer and PlaNet Finance look forward to sharing the results of this research with the Chinese government, in order to maximize its impact and reach throughout the country.

Related Articles Read More >

This is a photo of the Fujifilm Diosynth Biotechnologies plant under construction in Holly Springs, North Carolina.
Fujifilm, Regeneron ink $3B U.S. manufacturing agreement
This is the logo of Johnson & Johnson.
J&J breaks ground on $2B manufacturing facility in North Carolina
sherwin-williams-pharma-facility (1)
Sherwin-Williams expands flooring solutions for pharma facilities
PHARMAP 2025: Pharma leaders converge in Berlin for fifth anniversary summit
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE